Canaan on Twitter
Canaan on Facebook
Canaan on LinkedIn
© Copyright 2018 Canaan Partners |
The New Yorker: The RealReal’s radical vision of secondhand luxury
An inside look at how The RealReal is redefining consignment for its 8 million members (and counting).
More hope for cystic fibrosis treatment, and still more to do
The progress made in the treatment of CF is shows what can happen when research, policy, advocacy and investment align toward a common goal. But more has to be done.
The Next Generation of Computation
Professor Robert Schoelkopf of QCI inside a lab at Yale University. Photo Credit: Roger Kisby for The New York Times
Spotlight on Wende Hutton’s 25 years in venture capital
General Partner Wende Hutton is an industry pioneer. Partner Julie Grant chatted with Wende about today’s scientific renaissance, the importance of a team approach and the difference between active and activist investor.
Video: Introducing The Makers, featuring Dan Ciporin & Amir Ashkenazi
The Makers is a new Canaan content series featuring entrepreneur and investor insights into company-building.
A Critical Marriage for Science and Health Tech
The prehistoric nature of health IT isn’t just a nuisance. It will literally determine whether patients and physicians can realize the potential of cell and gene therapies.
What Home Is
Meet our newest investment Homeis. A new kind of social network that connects foreign born locals with one another, and their roots.
What's Rarer than a Unicorn in Silicon Valley? A Female VC.
Canaan Associate Laura Chau reflects on the 3 major takeaways she's learned from women in venture capital
IDEAYA & the Next Frontier in Synthetic Lethality
WSJ: Ideaya Biosciences Collects $94 Million for Cancer Therapy
The Roadmap for Board Diversity
Diversity is not window dressing. It is a positive predictor of performance and governance.
Built to Last
Excited to share news about our new $800 million fund. We know what works and we're sticking to it with our diversified, early stage approach.
New York Times: A chicken sandwich hitches a balloon ride to the stratosphere.
Spotlight: Q&A with Rich Boyle
Get to know our newest GP and longtime startup operator Rich Boyle. Word to the wise: don't throw the term AI around with him unless you mean it.
Heavy drinking is the largest ignored epidemic in the U.S. There is a superior alternative to rehab.
Body Politic Series: Women's access to healthcare
The first installment of this series couldn't have been more timely.
A simple promise: replacing injections with pills.
Endpoints News: Brent Aherns weights in on FDA's new reimbursement idea for antibiotics
Takeaways on European Fintech & Money2020
Scientific American: New thalidomide-like therapy hijacks cells’ trash-disposal system
Fortune: Ticketfly Cofounder and Monero Ringmaster Start New Blockchain Project, Tari
Video: Brendan Dickinson on how to raise money in fintech at the 2018 Empire Startups conference
Fierce Biotech: Mackay’s Rallybio rare disease startup raises $37M in first funding round
Business Insider: Adina Tecklu named under 30 rising star in Silicon Valley tech scene
Endpoints Under 40 Feature: Julie Grant’s views on the future of biopharma
Practical tips from two male biotech CEOs who are leaning in
Anil Singhal: My four takeaways from the AACR annual meeting
Fintech Central: Three big takeaways on how data is changing investing as we know it
FierceBiotech: GV, Roche help Ideaya to $94M crossover round, setting stage for synthetic lethality, I-O trials
STAT News: Julie Grant on how biotech’s latest bubble might go pop
Fox Business: Dan Ciporin on Mornings with Maria discussing cryptocurrency
The Consumerization of Enterprise & the Dropbox IPO
Business Insider: Wende Hutton who’s worked in venture capital for 25 years shares her best career advice — and why it was worth being the first and only woman on her team when she started out
Fortune Term Sheet: Rich Boyle – 5 Qs with a dealmaker
TechCrunch: Uncommon.co launches and raises $18m to bring objectivity and efficiency to hiring
Bloomberg Tech: Canaan Partners see race for firms to hire more women
VentureBeat: ContentSquare lands $42 million so AI can track how you click, touch, and interact with brands
Endpoints News: When VCs hand out mega-rounds to Vir and Gossamer, are they betting on the jockey or the horse?
TechCrunch: Apartment List raises $50 million for home rentals
CNBC: After a miserable 2017, VCs offer predictions on digital health IPOs for 2018
C&EN: Investment flows at J.P. Morgan Healthcare Conference
Endpoints News: The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds
FierceBiotech: Arvinas in $830M-plus Pfizer biobucks deal
Business Insider: AOL’s former head of video has raised money to build a Facebook-plus-Yelp-plus-Tinder for immigrants
FiercePharma: 2017’s fiercest women in life sciences
Rock Health: Meet the 2018 top 50 in digital health honorees
Boston Globe: Startup promises a weather report just for your block
Endpoints News: Six top biotech VCs take a look at the latest trends, and offer their thoughts on 2018
BioCentury Innovations: How Vivace turns the YAP pathway off or on to treat cancer
Endpoints News: Genentech inks $650M deal with protein degradation pioneer Arvinas
NY Times: Yale professors race Google and IBM to the first quantum computer
Fortune: Top women investors are answering the VC boys’ club with one of their own
VentureForward Blog: Canaan Forward – Diversity as an Asset
CNBC: 11 women who prove that health tech investing isn’t a boys’ club
Business Insider: Meet the 30 biotech leaders under 40 who are shaping the future of medicine
Recode Decode: Why one venture capitalist is ‘cringing’ at recent tech IPOs
WIRED: ExecThread opens a secret job board to the masses
The Marketing Power of UX Optimization
Entrepreneur: Why this ruthlessly prioritizing entrepreneur says you should write down one goal each day
Bloomberg: America’s drinking problem is much worse this century
Fierce Biotech: Canaan unveils $800 million fund for fresh wave of biotech bets
Women of Venture in Healthcare: 30x return on investment . . . in each other
TechCrunch: Canaan Partners just closed on its biggest fund (by a lot)
WSJ: Canaan’s $800 million fund is the latest jumbo-size capital pool
Running a Successful SaaS Fundraising Process
Bloomberg: Canaan’s Ibrahim on VC funding environment, harassment
Fast Company: 4 life insurance startups asking millenials to face their mortality
Fierce Biotech: Vivace uncloaks with $40M, U.S./China backing for cancer trials
TechCrunch: Diabetes management platform Glooko raises $35 million
CNBC: Startup execs urge Trump not to kill the special ‘startup visa’ for entrepreneurs
TechCrunch: In wake of Amazon/Whole Foods deal, Instacart has a challenging opportunity
LA Times: Silicon Valley’s acquisition targets aren’t in tech anymore
Variety: Tubular Labs launches branded content video tracker
Michael Beckerman: On the startup road: Canaan Partners
CNBC: A big problem with genetic testing is figuring out what the results mean. Startup Genome Medical aims to help
WSJ: Civic-based tech sees a surge
TechCrunch: What venture capitalists think of Trump
Brendan Dickinson in American Banker: As VCs pivot from lenders, case for deposit-side fintech is less clear
CNBC: Tech VCs are barging into life sciences, and writing big checks
Fintech Central: Blockchain will never work in financial services & bitcoin is here to stay
Quartz: Jeff Bezos says he’s putting billions into space. He’s not alone.
TechCrunch Equity Podcast with Maha and Hrach: Dropbox’s capital appetite and average revenue per dog
TechCrunch: Gaming company Kabam’s roller coaster ride to an $800M exit
STAT: Biotech dreams of drugging the “undruggable”
BioTech Nation: Women in biotech venture capital
Tim Shannon in STAT: What Trump gets wrong about drug companies
TechCrunch: Zugata raises $7 million to make annual performance reviews obsolete
WSJ: Venture capital prowls into the life insurance business
SaaSQ: Building a $4B company in Silicon Valley as an outsider
You Can’t Manage What You Can’t Measure
FinTech Central: Bitcoin is not “closing”! And other misconceptions debunked.
Elephant hunting in the HR software jungle
Brendan Dickinson: Growth Marketing: A conversation with Will Young
Nina Kjellson: Why I’m excited to help reinvent treatment for heavy drinking
FinTech Central: Working with the regulator
Tim Shannon: Durable bonds and the birth of Vivace Therapeutics
Steve Bloch: Breaking down barriers in genomic medicine
Brendan Dickinson: Complex logistics – a conversation with Seth Goldman, former CEO of HelloFresh USA
FinTech Central: The 2nd wave of fintech
SaaSQ: How to build a billion-dollar company that delivers happiness
Rayfe Gaspar-Asaoka: How to cut through the AI hype
Colleen Cuffaro: Arrakis Therapeutics: Redefining the druggable target
Joydeep Bhattacharyya: Five things every immigrant entrepreneur should do
Deepak Kamra: Capella Space: Getting the full picture
Why I led Ladder’s Series A
Insurance is the next frontier for fintech
We met the dynamic duo. (And they weren’t wearing capes.)
Chats + AI: Changing the face of CRM